Ask about this productRelated genes to: RHCE antibody
- Gene:
- RHCE NIH gene
- Name:
- Rh blood group CcEe antigens
- Previous symbol:
- RH
- Synonyms:
- CD240CE
- Chromosome:
- 1p36.11
- Locus Type:
- gene with protein product
- Date approved:
- 1993-10-22
- Date modifiied:
- 2019-04-23
Related products to: RHCE antibody
Related articles to: RHCE antibody
- Serologic typing for ABO and RhD is standard in transfusion services, with extended serology and genotyping performed to reduce red cell alloimmunization risk. In Kenya, RH typing is limited to RhD, and genotyping is unavailable. This study used RHD/RHCE genotyping to predict phenotypes and their distribution in a Kenyan blood donor population. - Source: PubMed
Publication date: 2026/04/22
Sowah Sandra APerros Alexis JGithiomi RachelLopez Genghis HObiero CelestinoPerera Thilini NRoulis EileenFlower Robert LHyland Catherine A - - Source: PubMed
Publication date: 2026/04/22
Heng EvelyneNeto Braga GabrielBranger MarineFlammang MyleneTournamille ChristopheFloch Aline - - Source: PubMed
Publication date: 2026/04/16
Voreux RébeccaVege SunithaCrépin OdileFlahaut RaynaldRicard CélineOchoa-Garay GorkaHomich ChloeSachais Bruce SRahorst LynsiVelliquette Randall WBarrault AurélieTournamille ChristopheFloch Aline - Patients with chronic transfusion needs such as those with sickle cell disease face a high risk of developing antibodies against high-prevalence antigens in the RH blood group system, complicating transfusion therapy and potentially necessitating stem cell transplantation. Molecular characterization of the RH system is hindered by hybrid alleles and high sequence homology between RHD and RHCE, limiting the effectiveness of conventional short-read sequencing. - Source: PubMed
Publication date: 2026/04/08
Waldmann RebekkaFührer MaritaVogt AnnikaNolde DominikRiecker MelanieHerrlich Lennart FinnDinse TimoSchrezenmeier HubertWeinstock ChristofMesserer David Alexander Christian - According to ISO 10993-23 (Biological evaluation of medical devices - Part 23: Tests for irritation, Annex D2), no specific alternative test method has yet been established to identify substances that may cause eye irritation or serious eye damage in medical devices. Therefore, the in vivo animal test OECD TG 405 continues to be used. This study adapted the in vitro eye irritation test (EIT) using the MCTT HCE™ Reconstructed Human Corneal Epithelial (RHCE) model, which was originally developed for testing chemicals, to the testing of ophthalmic medical devices such as contact lenses and intraocular lenses. A validation study, carried out in accordance with OECD GD 34, aimed to confirm transferability (2 produced medical devices and 2 spiked extract vehicles), proficiency (4 produced medical devices and 3 spiked extract vehicles), and reproducibility (8 produced medical devices and 9 spiked extract vehicles). The results demonstrated a combined predictive capacity of 89.6% sensitivity, 87.3% specificity, and 88.4% accuracy based on 285 runs. Specifically, the test showed 85.7% sensitivity, 100% specificity, and 92.9% accuracy for classifying produced medical devices (140 runs) and 93.8% sensitivity, 76.3% specificity, and 84.1% accuracy for classifying solutions spiked with chemicals before extraction (145 runs). These findings confirm the reliability of the 'MCTT HCE™ EIT for medical devices' in assessing the irritation potential of medical device extracts, including the detection of low concentrations of potent irritants. - Source: PubMed
Publication date: 2026/03/26
Kang Nam-HeeKim SeolyeongLee SubinPark JungeunJung Mi-SookAn Hyo-JuGo Min-GyuKim JoohwanWoo Sun Wook